» Articles » PMID: 16462803

Design and Use of Conditional MHC Class I Ligands

Overview
Journal Nat Med
Date 2006 Feb 8
PMID 16462803
Citations 178
Authors
Affiliations
Soon will be listed here.
Abstract

Major histocompatibility complex (MHC) class I molecules associate with a variety of peptide ligands during biosynthesis and present these ligands on the cell surface for recognition by cytotoxic T cells. We have designed conditional MHC ligands that form stable complexes with MHC molecules but degrade on command, by exposure to a defined photostimulus. 'Empty MHC molecules' generated in this manner can be loaded with arrays of peptide ligands to determine MHC binding properties and to monitor antigen-specific T-cell responses in a high-throughput manner. We document the value of this approach by identifying cytotoxic T-cell epitopes within the H5N1 influenza A/Vietnam/1194/04 genome.

Citing Articles

CryoEM structure of an MHC-I/TAPBPR peptide-bound intermediate reveals the mechanism of antigen proofreading.

Sun Y, Pumroy R, Mallik L, Chaudhuri A, Wang C, Hwang D Proc Natl Acad Sci U S A. 2025; 122(2):e2416992122.

PMID: 39786927 PMC: 11745410. DOI: 10.1073/pnas.2416992122.


DNA barcoded peptide-MHC multimers to measure and monitor minor histocompatibility antigen-specific T cells after allogeneic stem cell transplantation.

Fuchs K, Goransson M, Kester M, Ettienne N, van de Meent M, de Jong R J Immunother Cancer. 2024; 12(12).

PMID: 39653555 PMC: 11629015. DOI: 10.1136/jitc-2024-009564.


Neoantigen immunogenicity landscapes and evolution of tumor ecosystems during immunotherapy with nivolumab.

Alban T, Riaz N, Parthasarathy P, Makarov V, Kendall S, Yoo S Nat Med. 2024; 30(11):3209-3222.

PMID: 39349627 DOI: 10.1038/s41591-024-03240-y.


Harnessing microbial antigens as cancer antigens: a promising avenue for cancer immunotherapy.

Zhang T, Zhang X, Chen J, Zhang X, Zhang Y Front Immunol. 2024; 15:1411490.

PMID: 39139570 PMC: 11319170. DOI: 10.3389/fimmu.2024.1411490.


Development of a Stable Peptide-Major Histocompatibility Complex (MHC) via Sortase and Click Chemistry.

Uslu S, Lee U, Tavakolpour S, Abousaway O, Nili A, Bass L ACS Pharmacol Transl Sci. 2024; 7(6):1746-1757.

PMID: 38898944 PMC: 11184609. DOI: 10.1021/acsptsci.3c00268.